Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Court Blocks FDA’s Attempt To Ban Electroshock Device

Executive Summary

The DC Circuit Court of Appeals says the US agency can’t ban a device for certain indications while allowing it to remain on the market for others.

You may also be interested in...

Year-End Spending Bill Sets FDA 2023 Budget At $6.6B

In addition to higher spending, the omnibus package now before the US Congress also addresses dual submissions, cybersecurity, pandemic preparedness, and more.  

Lawyers Say Jackson’s Supreme Court Impact Could Be Felt On Administrative, Patent Cases

As confirmation hearings for Judge Ketanji Brown Jackson continue, MTI took a look at some of the core areas at stake. 

Shock-Treatment Tool Becomes Third Device Type Banned By FDA

The US agency has banned the use of electrical stimulation devices (ESDs) to prevent self-injurious or aggressive behavior. The ban was first recommended at a 2014 FDA panel hearing and is widely supported by the disability community. The move by the agency is rare; it’s only the third time a medical device has been completely blocked from use in the US.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts